Skip to main content
SpringerLink
Log in

Description of Turner Syndrome

  • Chapter
  • First Online:
Turner Syndrome

  • 1076 Accesses

Abstract

Turner syndrome describes females who have partial or complete absence of the second sex chromosome and can present with a variety of phenotypic and genotypic features. This chapter serves to summarize many of these features as well as provide an overview of clinical management guidelines. Incidence and karyotype findings are discussed prior to an overview of phenotype, commenting on skeletal manifestations, ovarian failure, cardiovascular and heart disease, lymphatic obstruction, renal abnormalities, autoimmune diseases, psychological and cognitive implications, and malignancy risk. Many of the topics introduced in this chapter will be described in further detail in subsequent chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bondy CA, Turner Syndrome Study G. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10–25.

    Article  CAS  PubMed  Google Scholar 

  2. Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1–G70.

    Article  CAS  PubMed  Google Scholar 

  3. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;87(1):81–3.

    Article  CAS  PubMed  Google Scholar 

  4. Gunther DF, Eugster E, Zagar AJ, Bryant CG, Davenport ML, Quigley CA. Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics. 2004;114(3):640–4.

    Article  PubMed  Google Scholar 

  5. Kagan KO, Hoopmann M, Singer S, Schaeferhoff K, Dufke A, Mau-Holzmann UA. Discordance between ultrasound and cell free DNA screening for monosomy X. Arch Gynecol Obstet. 2016;294(2):219–24.

    Article  PubMed  Google Scholar 

  6. Savendahl L, Davenport ML. Delayed diagnoses of Turner’s syndrome: proposed guidelines for change. J Pediatr. 2000;137(4):455–9.

    Article  CAS  PubMed  Google Scholar 

  7. Spatz A, Borg C, Feunteun J. X-chromosome genetics and human cancer. Nat Rev Cancer. 2004;4(8):617–29.

    Article  CAS  PubMed  Google Scholar 

  8. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95(4):1487–95.

    Article  CAS  PubMed  Google Scholar 

  9. Matsumoto F, Shimada K, Ida S. Tumors of bilateral streak gonads in patients with disorders of sex development containing y chromosome material. Clin Pediatr Endocrinol. 2014;23(3):93–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tam YH, Wong YS, Pang KK, et al. Tumor risk of children with 45,X/46,XY gonadal dysgenesis in relation to their clinical presentations: Further insights into the gonadal management. J Pediatr Surg. 2016;51(9):1462–6.

    Article  PubMed  Google Scholar 

  11. Coyle D, Kutasy B, Han Suyin K, et al. Gonadoblastoma in patients with 45,X/46,XY mosaicism: a 16-year experience. J Pediatr Urol. 2016;12(5):283.e1–7.

    Article  Google Scholar 

  12. Flannigan RK, Chow V, Ma S, Yuzpe A. 45,X/46,XY mixed gonadal dysgenesis: a case of successful sperm extraction. Can Urol Assoc J. 2014;8(1–2):E108–10.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Landin-Wilhelmsen K, Bryman I, Hanson C, Hanson L. Spontaneous pregnancies in a Turner syndrome woman with Y-chromosome mosaicism. J Assist Reprod Genet. 2004;21(6):229–30.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kuntsi J, Skuse D, Elgar K, Morris E, Turner C. Ring-X chromosomes: their cognitive and behavioural phenotype. Ann Hum Genet. 2000;64(Pt 4):295–305.

    Article  CAS  PubMed  Google Scholar 

  15. Fukami M, Seki A, Ogata T. SHOX haploinsufficiency as a cause of syndromic and nonsyndromic short stature. Mol Syndromol. 2016;7(1):3–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Malaquias AC, Scalco RC, Fontenele EG, et al. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis. Horm Res Paediatr. 2013;80(6):449–56.

    Article  CAS  PubMed  Google Scholar 

  17. Huguet S, Leheup B, Aslan M, et al. Radiological and clinical analysis of Madelung’s deformity in children. Orthop Traumatol Surg Res. 2014;100(6 Suppl):S349–52.

    Article  CAS  PubMed  Google Scholar 

  18. Davenport ML, Crowe BJ, Travers SH, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92(9):3406–16.

    Article  CAS  PubMed  Google Scholar 

  19. Bondy CA, Van PL, Bakalov VK, Ho VB. Growth hormone treatment and aortic dimensions in Turner syndrome. J Clin Endocrinol Metab. 2006;91(5):1785–8.

    Article  CAS  PubMed  Google Scholar 

  20. Davenport ML, Roush J, Liu C, et al. Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome. Horm Res Paediatr. 2010;74(1):23–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Irzyniec TJ, Jez W. The influence of hormonal replacement and growth hormone treatment on the lipids in Turner syndrome. Gynecol Endocrinol. 2014;30(3):250–3.

    Article  CAS  PubMed  Google Scholar 

  22. Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm Res. 2009;71(6):336–42.

    CAS  PubMed  Google Scholar 

  23. Bakalov VK, Van PL, Baron J, Reynolds JC, Bondy CA. Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab. 2004;89(10):4886–9.

    Article  CAS  PubMed  Google Scholar 

  24. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev. 2012;9(Suppl 2):713–7.

    PubMed  Google Scholar 

  25. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab. 1997;82(6):1810–3.

    CAS  PubMed  Google Scholar 

  26. Bernard V, Donadille B, Zenaty D, et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod. 2016;31(4):782–8.

    Article  PubMed  Google Scholar 

  27. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner’s syndrome. J Clin Endocrinol Metab. 1998;83(9):3198–204.

    CAS  PubMed  Google Scholar 

  28. Quigley CA, Wan X, Garg S, Kowal K, Cutler GB Jr, Ross JL. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014;99(9):E1754–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Oktay K, Bedoschi G, Berkowitz K, et al. Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2015;29(5):409–16.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Practice Committee of American Society For Reproductive M. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril. 2012;97(2):282–4.

    Google Scholar 

  31. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr. 1998;133(5):688–92.

    Article  CAS  PubMed  Google Scholar 

  32. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child. 1994;71(5):433–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Berdahl LD, Wenstrom KD, Hanson JW. Web neck anomaly and its association with congenital heart disease. Am J Med Genet. 1995;56(3):304–7.

    Article  CAS  PubMed  Google Scholar 

  34. Loscalzo ML, Van PL, Ho VB, et al. Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics. 2005;115(3):732–5.

    Article  PubMed  Google Scholar 

  35. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young. 2006;16(5):430–6.

    Article  PubMed  Google Scholar 

  36. Bondy CA. Aortic dissection in Turner syndrome. Curr Opin Cardiol. 2008;23(6):519–26.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Los E, Quezada E, Chen Z, Lapidus J, Silberbach M. Pilot study of blood pressure in girls with Turner syndrome: an awareness gap, clinical associations, and new hypotheses. Hypertension. 2016;68:133.

    Article  CAS  PubMed  Google Scholar 

  38. Elsheikh M, Casadei B, Conway GS, Wass JA. Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome. Clin Endocrinol. 2001;54(1):69–73.

    Article  CAS  Google Scholar 

  39. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics G. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008;93(12):4735–42.

    Article  CAS  PubMed  Google Scholar 

  40. Mavinkurve M, O’Gorman CS. Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome. BBA Clin. 2015;3:304–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Bilge I, Kayserili H, Emre S, et al. Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children. Pediatr Nephrol. 2000;14(12):1111–4.

    Article  CAS  PubMed  Google Scholar 

  42. Livadas S, Xekouki P, Fouka F, et al. Prevalence of thyroid dysfunction in Turner’s syndrome: a long-term follow-up study and brief literature review. Thyroid. 2005;15(9):1061–6.

    Article  CAS  PubMed  Google Scholar 

  43. Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87(12):5495–8.

    Article  CAS  PubMed  Google Scholar 

  44. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40(1):1–19.

    Article  PubMed  Google Scholar 

  45. Jorgensen KT, Rostgaard K, Bache I, et al. Autoimmune diseases in women with Turner’s syndrome. Arthritis Rheum. 2010;62(3):658–66.

    Article  PubMed  CAS  Google Scholar 

  46. Ross J, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment Retard Dev Disabil Res Rev. 2000;6(2):135–41.

    Article  CAS  PubMed  Google Scholar 

  47. McCauley E, Feuillan P, Kushner H, Ross JL. Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr. 2001;22(6):360–5.

    Article  CAS  PubMed  Google Scholar 

  48. Ji J, Zoller B, Sundquist J, Sundquist K. Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a national cohort study. Int J Cancer. 2016;139(4):754–8.

    Article  CAS  PubMed  Google Scholar 

  49. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, Group UKCC. Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol. 2008;9(3):239–46.

    Article  PubMed  Google Scholar 

  50. Hasle H, Olsen JH, Nielsen J, Hansen J, Friedrich U, Tommerup N. Occurrence of cancer in women with Turner syndrome. Br J Cancer. 1996;73(9):1156–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Larizza D, Albanesi M, De Silvestri A, et al. Neoplasia in Turner syndrome. The importance of clinical and screening practices during follow-up. Eur J Med Genet. 2016;59(5):269–73.

    Article  PubMed  Google Scholar 

  52. Bell J, Parker KI, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010;95(2):167–77.

    Article  CAS  PubMed  Google Scholar 

  53. Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormonein Turner syndrome. J Clin Endocrinol Metab. 2008;93(1):344–51.

    Article  CAS  PubMed  Google Scholar 

  54. Child CJ, Zimmermann AG, Chrousos GP, et al. Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program. J Clin Endocrinol Metab. 2019;104(2):379–89.

    Article  PubMed  Google Scholar 

  55. Pier DB, Nunes FP, Plotkin SR, et al. Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome. Eur J Med Genet. 2014;57(6):269–74.

    Article  PubMed  Google Scholar 

  56. Alexiou GA, Varela M, Dimitriadis E, et al. Brain tumors in Turner syndrome. Eur J Med Genet. 2014;57(6):312–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA

    Alissa J. Roberts & Patricia Y. Fechner

Authors
  1. Alissa J. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia Y. Fechner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alissa J. Roberts .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA

    Patricia Y. Fechner

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Roberts, A.J., Fechner, P.Y. (2020). Description of Turner Syndrome. In: Fechner, P. (eds) Turner Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-34150-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-34150-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-34148-0

  • Online ISBN: 978-3-030-34150-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation